Crafting Docetaxel-Loaded Albumin Nanoparticles Through a Novel Thermal-Driven Self-Assembly/Microfluidic Combination Technology: Formulation, Process Optimization, Stability, and Bioavailability

References

• Jurczyk M, Kasperczyk J, Wrzesniok D, et al. Nanoparticles loaded with docetaxel and resveratrol as an advanced tool for cancer therapy. Biomedicines. 2022;10(5):1187. doi:10.3390/biomedicines10051187
   PubMed Web of Science ®Google Scholar
• Al-Nemrawi NK, Altawabeyeh RM, Darweesh RS. Preparation and characterization of docetaxel-PLGA nanoparticles coated with folic acid-chitosan conjugate for cancer treatment. J Pharm Sci. 2022;111(2):485–494. doi:10.1016/j.xphs.2021.10.034
   PubMed Web of Science ®Google Scholar
• Zhu XJ, Yu ZJ, Feng LB, et al. Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer. Carbohydr Polym. 2021;268:118237. doi:10.1016/j.carbpol.2021.118237
   PubMed Web of Science ®Google Scholar
• Emami J, Kazemi M, Hasanzadeh F, et al. Novel pH-triggered biocompatible polymeric micelles based on heparin-alpha-tocopherol conjugate for intracellular delivery of docetaxel in breast cancer. Pharm Dev Technol. 2020;25(4):492–509. doi:10.1080/10837450.2019.1711395
   PubMed Web of Science ®Google Scholar
• Gu ZL, Wang QJ, Shi YB, et al. Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity. J Control Release. 2018;286:369–380. doi:10.1016/j.jconrel.2018.08.011
   PubMed Web of Science ®Google Scholar
• Vakili-Ghartavol R, Mehrabian A, Mirzavi F, et al. Docetaxel in combination with metformin enhances antitumour efficacy in metastatic breast carcinoma models: a promising cancer targeting based on PEGylated liposomes. J Pharm Pharmacol. 2022;74(9):1307–1319. doi:10.1093/jpp/rgac048
   PubMed Web of Science ®Google Scholar
• Jain S, Deore SV, Ghadi R, et al. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy. Mater Sci Eng C Mater Biol Appl. 2021;121:111832. doi:10.1016/j.msec.2020.111832
   PubMed Web of Science ®Google Scholar
• Gu ZL, Da Silva CG, Hao Y, et al. Effective combination of liposome-targeted chemotherapy and PD-L1 blockade of murine colon cancer. J Control Release. 2023;353:490–506. doi:10.1016/j.jconrel.2022.11.049
   PubMed Web of Science ®Google Scholar
• Tran P, Nguyen TN, Lee Y, et al. Docetaxel-loaded PLGA nanoparticles to increase pharmacological sensitivity in MDA-MB-231 and MCF-7 breast cancer cells. Korean J Physiol Pharmacol. 2021;25(5):479–488. doi:10.4196/kjpp.2021.25.5.479
   PubMed Web of Science ®Google Scholar
• Ren LL, Nie JF, Wei J, et al. RGD-targeted reDTX responsive nano micelle: co-loading docetaxel and indocyanine green to treat the tumor. Drug Deliv. 2021;28(1):2024–2032. doi:10.1080/10717544.2021.1977425
   PubMed Web of Science ®Google Scholar
• Tao J, Diao L, Chen FC, et al. pH-sensitive nanoparticles codelivering docetaxel and dihydroartemisinin effectively treat breast cancer by enhancing reactive oxidative species-mediated mitochondrial apoptosis. Mol Pharm. 2021;18(1):74–86. doi:10.1021/acs.molpharmaceut.0c00432
   PubMedGoogle Scholar
• Wang WP, Lei YY, Sui H, et al. Fabrication and evaluation of nanoparticle-assembled BSA microparticles for enhanced liver delivery of glycyrrhetinic acid. Artif Cells Nanomed Biotechnol. 2017;45(4):740–747. doi:10.1080/21691401.2016.1193024
   PubMed Web of Science ®Google Scholar
• Desale JP, Swami RJ, Kushwah V, et al. Chemosensitizer and docetaxel-loaded albumin nanoparticle: overcoming drug resistance and improving therapeutic efficacy. Nanomedicine. 2018;13(21):2759–2776. doi:10.2217/nnm-2018-0206
   PubMed Web of Science ®Google Scholar
• Huang YK, Hu L, Huang S, et al. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration. Int J Nanomed. 2018;13:8309–8323. doi:10.2147/IJN.S184379
   PubMed Web of Science ®Google Scholar
• Sleep D. Albumin and its application in drug delivery. Expert Opin Drug Deliv. 2015;12(5):793–812. doi:10.1517/17425247.2015.993313
   PubMed Web of Science ®Google Scholar
• Wang YF, Chen S, Yang X, et al. Preparation optimization of bovine serum albumin nanoparticles and its application for siRNA delivery. Drug Des Devel Ther. 2021;15:1531–1547. doi:10.2147/DDDT.S299479
   PubMed Web of Science ®Google Scholar
• Desai NP, Soon-Shiong P Therapy for breast cancer based on hormone receptor status with nanoparticles comprising taxane. United States Patent, Patent No: US 8999 396 B2. 2015 Apr 7.
   Google Scholar
• Lluch A, Alvarez I, Munoz M, et al. Treatment innovations for metastatic breast cancer: nanoparticle ´ albumin-bound (NAB) technology targeted to tumors. Crit Rev Oncol Hematol. 2014;89(1):62–72. doi:10.1016/j.critrevonc.2013.08.001
   PubMed Web of Science ®Google Scholar
• Miele E, Spinelli GP, Miele E, et al. Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer. Int J Nanomed. 2009;4:99–105. doi:10.2147/ijn.s3061
   PubMed Web of Science ®Google Scholar
• Sristi, Fatima M, Sheikh A, et al. Recent advancement on albumin nanoparticles in treating lung carcinoma. J Drug Target. 2023;31(5):486–499. doi:10.1080/1061186X.2023.2205609
   PubMed Web of Science ®Google Scholar
• Yuan DM, Lv YL, Yao YW, et al. Efficacy and safety of Abraxane in treatment of progressive and recurrent non-small cell lung cancer patients: a retrospective clinical study. Thorac Cancer. 2012;3(4):341–347. doi:10.1111/j.1759-7714.2012.00113.x
   PubMed Web of Science ®Google Scholar
• Herper M. Celgene’s Abraxane extends life by 1.8 months in advanced pancreatic cancer. Forbes com. 2013;23:9.
   Google Scholar
• Loureiro A, Azoia NG, Gomes AC, et al. Albumin-based nanodevices as drug carriers. Curr Pharm Des. 2016;22(10):1371–1390. doi:10.2174/1381612822666160125114900
   PubMed Web of Science ®Google Scholar
• Rostamabadi H, Falsafi SR, Jafari SM. Starch-based nanocarriers as cutting-edge natural cargos for nutraceutical delivery. Trends Food Sci Technol. 2019;88:397–415. doi:10.1016/j.tifs.2019.04.004
   Web of Science ®Google Scholar
• Arpagaus C, Collenberg A, Rutti D, et al. Nano spray drying for encapsulation of pharmaceuticals. Int J Pharm. 2018;546(1–2):194–214. doi:10.1016/j.ijpharm.2018.05.037
   PubMed Web of Science ®Google Scholar
• Strojewski D, Krupa A. Spray drying and nano spray drying as manufacturing methods of drug-loaded polymeric particles. Polim Med. 2022;52(2):101–111. doi:10.17219/pim/152230
   PubMedGoogle Scholar
• Fu Q, Sun J, Zhang WP, et al. Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery. Recent Pat Anticancer Drug Discov. 2009;4(3):262–272. doi:10.2174/157489209789206869
   PubMed Web of Science ®Google Scholar
• Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release. 2012;157(2):168–182. doi:10.1016/j.jconrel.2011.07.031
   PubMed Web of Science ®Google Scholar
• Solanki R, Rostamabadi H, Patel S, et al. Anticancer nano-delivery systems based on bovine serum albumin nanoparticles: a critical review. Int J Biol Macromol. 2021;193:528–540. doi:10.1016/j.ijbiomac.2021.10.040
   PubMed Web of Science ®Google Scholar
• Hassanin IA, Elzoghby AO. Self-assembled non-covalent protein-drug nanoparticles: an emerging delivery platform for anti-cancer drugs. Expert Opin Drug Deliv. 2020;17(10):1437–1458. doi:10.1080/17425247.2020.1813713
   PubMed Web of Science ®Google Scholar
• Crisante F, Francolini I, Bellusci M, et al. Antibiotic delivery polyurethanes containing albumin and polyallylamine nanoparticles. Eur J Pharm Sci. 2009;36(4–5):555–564. doi:10.1016/j.ejps.2008.12.006
   PubMed Web of Science ®Google Scholar
• Langer K, Anhorn MG, Steinhauser I, et al. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation. Int J Pharm. 2008;347(1–2):109–117. doi:10.1016/j.ijpharm.2007.06.028
   PubMed Web of Science ®Google Scholar
• Yedomon B, Fessi H, Charcosset C. Preparation of Bovine Serum Albumin (BSA) nanoparticles by desolvation using a membrane contactor: a new tool for large scale production. Eur J Pharm Biopharm. 2013;85:398–405. doi:10.1016/j.ejpb.2013.06.014
   PubMed Web of Science ®Google Scholar
• Manz A, Graber N, Widmer HM. Miniaturized total chemical analysis systems: a novel concept for chemical sensing. Sensor Actuat B-Chem. 1990;1(1–6):244–248. doi:10.1016/0925-4005(90)80209-I
   Web of Science ®Google Scholar
• Kopp MRG, Linsenmeier M, Hettich B, et al. Microfluidic shrinking droplet concentrator for analyte detection and phase separation of protein solutions. Anal Chem. 2020;92(8):5803–5812. doi:10.1021/acs.analchem.9b05329
   PubMed Web of Science ®Google Scholar
• Chung MT, Kurabayashi K, Cai D. Single-cell RT-LAMP mRNA detection by integrated droplet sorting and merging. Lab Chip. 2019;19(14):2425–2434. doi:10.1039/c9lc00161a
   PubMed Web of Science ®Google Scholar
• Utharala R, Tseng QZ, Furlong EEM, et al. A versatile, low-cost, multiway microfluidic sorter for droplets, cells, and embryos. Anal Chem. 2018;90(10):5982–5988. doi:10.1021/acs.analchem.7b04689
   PubMed Web of Science ®Google Scholar
• Shang L, Cheng Y, Zhao YJ. Emerging droplet microfluidics. Chem Rev. 2017;117(12):7964–8040. doi:10.1021/acs.chemrev.6b00848
   PubMed Web of Science ®Google Scholar
• Liu DF, Zhang HB, Cito S, et al. Core/shell nanocomposites produced by superfast sequential microfluidic nanoprecipitation. Nano Lett. 2017;17(2):606–614. doi:10.1021/acs.nanolett.6b03251
   PubMed Web of Science ®Google Scholar
• Yang XL, Ju XJ, Mu XT, et al. Core-shell chitosan microcapsules for programmed sequential drug release. ACS Appl Mater Interfaces. 2016;8(16):10524–10534. doi:10.1021/acsami.6b01277
   PubMed Web of Science ®Google Scholar
• Maeki M, Ito S, Takeda R, et al. Room-temperature crystallography using a microfluidic protein crystal array device and its application to protein-ligand complex structure analysis. Chem Sci. 2020;11(34):9072–9087. doi:10.1039/d0sc02117b
   PubMed Web of Science ®Google Scholar
• Yang YY, Noviana E, Nguyen MP, et al. Paper-based microfluidic devices: emerging themes and applications. Anal Chem. 2017;89(1):71–91. doi:10.1021/acs.analchem.6b04581
   PubMed Web of Science ®Google Scholar
• Maeki M, Takeda R, Ishida A, et al. Real-time measurement of protein crystal growth rates within the microfluidic device to understand the microspace effect. ACS Omega. 2020;5(28):17199–17206. doi:10.1021/acsomega.0c01285
   PubMed Web of Science ®Google Scholar
• Song YL, Lin BQ, Tian T, et al. Recent progress in microfluidics-based biosensing. Anal Chem. 2019;91(1):388–404. doi:10.1021/acs.analchem.8b05007
   PubMed Web of Science ®Google Scholar
• Maeda H. Albumin-based drug delivery system targeting mannose receptors and its application to medical treatments. Yakugaku Zasshi. 2023;143(11):923–930. doi:10.1248/yakushi.23-00118
   PubMed Web of Science ®Google Scholar
• Meng R, Zhu HM, Deng PY, et al. Research progress on albumin-based hydrogels: properties, preparation methods, types and its application for antitumor-drug delivery and tissue engineering. Front Bioeng Biotechnol. 2023;11:1137145. doi:10.3389/fbioe.2023.1137145
   PubMed Web of Science ®Google Scholar
• Li F, Yeh S, Shi Q, et al. A novel thermal-driven self-assembly method to prepare albumin nanoparticles: formation kinetics, degradation behavior and formation mechanism. AAPS Pharm Sci Tech. 2022;23(7):250. doi:10.1208/s12249-022-02407-5
   PubMed Web of Science ®Google Scholar
• Qu N, Sun YT, Li YJ, et al. Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation. Biomed Eng Online. 2019;18(1):11. doi:10.1186/s12938-019-0624-7
   PubMedGoogle Scholar
• Asghar S, Salmani JMM, Hassan W, et al. A facile approach for crosslinker free nano self assembly of protein for anti-tumor drug delivery: factors’ optimization, characterization and in vitro evaluation. Eur J Pharm Sci. 2014;63:53–62. doi:10.1016/j.ejps.2014.06.022
   PubMed Web of Science ®Google Scholar
• Rahimnejad M, Bakeri G. Investigation and modeling effective parameters influencing the size of BSA protein nanoparticles as colloidal carrier. Colloids Surf A. 2012;412:96–100. doi:10.1016/j.colsurfa.2012.07.022
   Web of Science ®Google Scholar
• Holm NK, Jespersen SK, Thomassen LV, et al. Aggregation and fibrillation of bovine serum albumin. Biochim Biophys Acta. 2007;1774(9):1128–1138. doi:10.1016/j.bbapap.2007.06.008
   PubMed Web of Science ®Google Scholar
• Rohanizadeh R, Kokabi N. Heat denatured/aggregated albumin-based biomaterial: effects of preparation parameters on biodegradability and mechanical properties. J Mater Sci Mater Med. 2009;20(12):2413–2418. doi:10.1007/s10856-009-3819-9
   PubMed Web of Science ®Google Scholar
• Honda C, Kamizono H, Samejima T, et al. Studies on thermal aggregation of bovine serum albumin as a drug carrier. Chem Pharm Bull. 2000;48(4):464–466. doi:10.1248/cpb.48.464
   PubMed Web of Science ®Google Scholar
• Ebel C, Eisenberg H, Ghirlando R. Probing protein-sugar interactions. Biophys J. 2000;78:385–393.
   PubMedGoogle Scholar
• Taha M, Lee MJ. Interactions of TRIS [tris(hydroxymethyl)aminomethane] and related buffers with peptide backbone: thermodynamic characterization. Phys Chem Chem Phys. 2010;12(39):12840–12850. doi:10.1039/c0cp00253d
   PubMed Web of Science ®Google Scholar
• Shin JY, Cole BD, Seyedmohammad M, et al. Protein nanocarriers capable of encapsulating both hydrophobic and hydrophilic drugs. Methods Mol Biol. 2024;2720:143–150. doi:10.1007/978-1-0716-3469-1_10
   PubMedGoogle Scholar
• Agha A, Waheed W, Stiharu I, et al. A review on microfluidic-assisted nanoparticle synthesis, and their applications using multiscale simulation methods. Discov Nano. 2023;18(1):18. doi:10.1186/s11671-023-03792-x
   PubMedGoogle Scholar
• Yao FQ, Zhu PP, Chen JJ, et al. Synthesis of nanoparticles via microfluidic devices and integrated applications. Mikrochim Acta. 2023;190(7):256. doi:10.1007/s00604-023-05838-4
   PubMed Web of Science ®Google Scholar
• Fabozzi A, Sala FD, Di Gennaro M, et al. Design of functional nanoparticles by microfluidic platforms as advanced drug delivery systems for cancer therapy. Lab Chip. 2023;23(5):1389–1409. doi:10.1039/d2lc00933a
   PubMed Web of Science ®Google Scholar
• Zhang H, Yang J, Sun R, et al. Microfluidics for nano-drug delivery systems: from fundamentals to industrialization. Acta Pharm Sin B. 2023;13(8):3277–3299. doi:10.1016/j.apsb.2023.01.018
   PubMed Web of Science ®Google Scholar
• Tian F, Cai LL, Liu C, et al. Microfluidic technologies for nanoparticle formation. Lab Chip. 2022;22(3):512–529. doi:10.1039/d1lc00812a
   PubMed Web of Science ®Google Scholar
• Gimondi S, Ferreira H, Reis RL, et al. Microfluidic devices: a tool for nanoparticle synthesis and performance evaluation. ACS Nano. 2023;17(15):14205–14228. doi:10.1021/acsnano.3c01117
   PubMed Web of Science ®Google Scholar
• Fathordoobady F, Sannikova N, Guo YG, et al. Comparing microfluidics and ultrasonication as formulation methods for developing hempseed oil nanoemulsions for oral delivery applications. Sci Rep. 2021;11(1):72. doi:10.1038/s41598-020-79161-w
   PubMed Web of Science ®Google Scholar
• Carugo D, Bottaro E, Owen J, et al. Liposome production by microfluidics: potential and limiting factors. Sci Rep. 2016;6:25876. doi:10.1038/srep25876
   PubMed Web of Science ®Google Scholar
• Gdowski A, Johnson K, Shah S, et al. Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials. J Nanobiotechnol. 2018;16(1):12. doi:10.1186/s12951-018-0339-0
   PubMedGoogle Scholar
• Mishra V, Heath RJ. Structural and biochemical features of human serum albumin essential for eukaryotic cell culture. Int J Mol Sci. 2021;22(16):8411. doi:10.3390/ijms22168411
   PubMed Web of Science ®Google Scholar
• Tanjung YP, Dewi MK, Gatera VA, et al. Factors affecting the synthesis of bovine serum albumin nanoparticles using the desolvation method. Nanotechnol Sci Appl. 2024;17:21–40. doi:10.2147/NSA.S441324
   PubMed Web of Science ®Google Scholar
• Victor O, Cheng S, Chaw CS. Desolvation conditions for production of sulfasalazine based albumin nanoparticles: physical properties. Pharm Front. 2019;1:e190006. doi:10.20900/pf20190006
   Google Scholar
• Bolje A, Gobec S. Analytical techniques for structural characterization of Proteins in solid pharmaceutical forms: an overview. Pharmaceutics. 2021;13(4):534. doi:10.3390/pharmaceutics13040534
   PubMed Web of Science ®Google Scholar
• Fan XC, Chen JJ, Shen Q. Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery. Int J Pharm. 2013;458(2):296–304. doi:10.1016/j.ijpharm.2013.10.036
   PubMed Web of Science ®Google Scholar
• Moreira TDS, Silva ADO, Vasconcelos BRF, et al. DOPE/CHEMS-based EGFR-targeted immunoliposomes for docetaxel delivery: formulation development, physicochemical characterization and biological evaluation on prostate cancer cells. Pharmaceutics. 2013;15(3):915. doi:10.3390/pharmaceutics15030915
   Google Scholar
• Gao XY, Liu N, Wang ZM, et al. Development and optimization of chitosan nanoparticle-based intranasal vaccine carrier. Molecules. 2021;27(1):204. doi:10.3390/molecules27010204
   PubMed Web of Science ®Google Scholar
• Rizvi SSB, Akhtar N, Minhas MU, et al. Synthesis and characterization of carboxymethyl chitosan nanosponges with cyclodextrin blends for drug solubility improvement. Gels. 2022;8(1):55. doi:10.3390/gels8010055
   PubMed Web of Science ®Google Scholar
• Galvan-Colorado C, Chanona-Perez JJ, Arredondo-Tamayo B, et al. Obtention of phycobiliprotein nanoparticles from spirulina (Arthrospira maxima) and its characterization by FTIR and microscopic techniques. Microsc Microanal. 2023;29:885–888. doi:10.1093/micmic/ozad067.437
   PubMedGoogle Scholar
• Eloy JO, Ruiz A, De lima FT, et al. EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells. Colloids Surf B Biointerfaces. 2020;194:111185. doi:10.1016/j.colsurfb.2020.111185
   PubMed Web of Science ®Google Scholar
• De Freitas GBL, De Almeida DJ, Carraro E, et al. Formulation, characterization, and in vitro/in vivo studies of capsaicin-loaded albumin nanoparticles. Mater Sci Eng C Mater Biol Appl. 2018;93:70–79. doi:10.1016/j.msec.2018.07.064
   PubMed Web of Science ®Google Scholar
• Bronze-Uhle ES, Costa BC, Ximenes VF, et al. Synthetic nanoparticles of bovine serum albumin with entrapped salicylic acid. Nanotechnol Sci Appl. 2016;10:11–21. doi:10.2147/NSA.S117018
   PubMed Web of Science ®Google Scholar
• Fang R, Jing H, Chai Z, et al. Study of the physicochemical properties of the BSA: flavonoid nanoparticle. Eur Food Res Technol. 2011;233:275–283.
   Web of Science ®Google Scholar
• Arriagada F, Gunther G, Zabala I, et al. Development and characterization of florfenicol-loaded BSA nanoparticles as controlled release carrier. AAPS Pharm Sci Tech. 2019;20(5):202. doi:10.1208/s12249-019-1419-7
   PubMed Web of Science ®Google Scholar
• Fonseca DP, Khalil NM, Mainardes RM. Bovine serum albumin-based nanoparticles containing resveratrol: characterization and antioxidant activity. J Drug Delivery Sci Technol. 2017;39:147–155. doi:10.1016/j.jddst.2017.03.017
   Web of Science ®Google Scholar
• Li Q, Chen F, Liu Y, et al. A novel albumin wrapped nanosuspension of meloxicam to improve inflammation-targeting effects. Int J Nanomed. 2018;13:4711–4725. doi:10.2147/IJN.S160714
   PubMed Web of Science ®Google Scholar
• Punam T, Rahul S, Sargar A, et al. Stability study of dosage form: an innovative step. World J Pharm Res. 2014;3(2):1031–1050.
   Google Scholar
• Aashigari S, Gound R, Sneha S, et al. Stability studies of pharmaceutical products. World J Pharm Res. 2019;8:479–492. doi:10.20959/wjpr20191-13872
   Google Scholar
• Ren YR, Feng Y, Xu KY, et al. Enhanced bioavailability of dihydrotanshinone I-bovine serum albumin nanoparticles for stroke therapy. Front Pharmacol. 2021;12:721988. doi:10.3389/fphar.2021.721988
   PubMed Web of Science ®Google Scholar
• Tartari APS, Mt F, Ziebarth J, et al. Bovine serum albumin nanoparticles enhanced the intranasal bioavailability of silybin in rats. Pharmaceutics. 2023;15(12):2648. doi:10.3390/pharmaceutics15122648
   PubMed Web of Science ®Google Scholar
• Younis FA, Saleh SR, El-Rahman SSA, et al. Preparation, physicochemical characterization, and bioactivity evaluation of berberine-entrapped albumin nanoparticles. Sci Rep. 2022;12(1):17431. doi:10.1038/s41598-022-21568-8
   PubMed Web of Science ®Google Scholar
• Wang ZL, Li ZW, Zhang D, et al. Development of etopo side-loaded bovine serum albumin nanosuspensions for parenteral delivery. Drug Deliv. 2015;22(1):79–85. doi:10.3109/10717544.2013.871600
   PubMed Web of Science ®Google Scholar
• Wei YF, Li LC, Xi YF, et al. Sustained release and enhanced bioavailability of injectable scutellarin-loaded bovine serum albumin nanoparticles. Int J Pharm. 2014;476(1–2):142–148. doi:10.1016/j.ijpharm.2014.09.038
   PubMedGoogle Scholar
• Amani S, Mahdavi A. pH-responsive hybrid magnetic polyelectrolyte complex based on alginate/BSA as efficient nanocarrier for curcumin encapsulation and delivery. Int J Biol Macromolecules. 2019;141:1258–1270. doi:10.1016/j.ijbiomac.2019.09.048
   PubMed Web of Science ®Google Scholar
• Nosrati H, Sharafi A, Danafar H, et al. Bovine serum albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug. Bioorg Chem. 2018;76:501–509. doi:10.1016/j.bioorg.2017.12.033
   PubMed Web of Science ®Google Scholar